| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.2M | — | -11.3% |
| Cost of Revenue | $2.9M | — | +1764.4% |
| R&D Expense | $3.9M | — | +14.1% |
| SG&A Expense | $4.7M | — | -17.7% |
| Operating Income | -$5.3M | — | -135.9% |
| Pre-tax Income | -$4.0M | — | -608.9% |
| Income Tax | -$589K | — | -263.4% |
| Net Income | -$3.5M | — | -746.2% |
| EPS (Basic) | -$0.05 | — | -400.0% |
| EPS (Diluted) | -$0.05 | — | -400.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $145.6M | -6.1% | -10.3% |
| Accounts Receivable | $4.5M | +37.9% | -37.4% |
| Inventory | $56.5M | +15.2% | -4.3% |
| Current Assets | $211.5M | -0.6% | -9.5% |
| Total Assets | $219.4M | -0.0% | -11.2% |
| Current Liabilities | $65.2M | +262.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.7M | — | -222.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | -$740K | — | -345.5% |
| Free Cash Flow | -$8.7M | — | -223.1% |
| +134.4% |
| Total Liabilities | $67.8M | +228.2% | +119.1% |
| Stockholders' Equity | $151.6M | -23.7% | -29.8% |